https://canadianhematologytoday.com/issue/feedCanadian Hematology Today2026-02-03T19:01:24+00:00Open Journal Systemshttps://canadianhematologytoday.com/article/view/5-s01-Anglin_et_alNavigating Sequencing in Relapsed/Refractory Multiple Myeloma: Canadian Experts Discuss the Evidence and the Evolving Options2026-01-30T17:50:13+00:00Peter AnglinPaola NeriJoshua RichterDarrell White<p>Relapsed and refractory (R/R) multiple myeloma presents increasingly complex therapeutic decisions. Clinicians must not only weigh efficacy and tolerability but consider how today’s treatment decisions will affect future options. In a roundtable discussion, myeloma experts discuss practical approaches to sequencing therapies across diverse patient scenarios.</p>2026-02-03T00:00:00+00:00Copyright (c) 2026 Canadian Hematology Today